Preclinical Evaluation of a Novel <sup>111</sup>In-Labeled Bombesin Homodimer for Improved Imaging of GRPR-Positive Prostate CancerGiuseppe Carlucci, Philip H. Elsinga, Zilin Yu et al.|Molecular Pharmaceutics|2013Cited by 21